Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coronary stent patent case resolution (again)

This article was originally published in The Gray Sheet

Executive Summary

A stent patent case that has been in federal court since the 1990s will get closer to possible resolution Sept. 30 when a federal judge in Delaware plans to issue final judgment, reinstating infringement damages plus interest from Boston Scientific and Medtronic to Johnson & Johnson/Cordis that were initially awarded in 2000. The infringement findings, relating to Cordis' Palmaz balloon expandable stent patent, and damages of $324 million from Boston Scientific and $271 million from Medtronic, were set aside in 2002 in response to appeals and other procedural steps. A new trial was ordered, and in 2005 a jury again found in favor of Cordis. Boston Scientific and Medtronic no longer offer stents using the infringing platforms. On Sept. 15, Judge Sue Robinson rejected Boston Scientific's motion for yet another new trial, a decision that the firm plans to appeal
Advertisement

Related Content

J&J scores $1.2 bil. in stent patent fight
Advertisement
UsernamePublicRestriction

Register

MT026583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel